<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the World Health Organization classification, cases with classical Burkitt morphologic features and a very high proliferation fraction but without the MYC translocation are not clearly designated as a separate entity and are usually categorized as diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We identified from our records 33 cases of highly aggressive mature B-cell <z:hpo ids='HP_0002664'>neoplasms</z:hpo> from 8 children and 25 adults with typical Burkitt cytomorphologic, histologic, and immunophenotypic (CD20+/CD10+ and surface immunoglobulin-positive) features </plain></SENT>
<SENT sid="2" pm="."><plain>Rearrangement of MYC (MYC+) was present in only 18 of 33 cases, but the proliferation fraction was more than 90% in <z:hpo ids='HP_0000001'>all</z:hpo> MYC-cases (no MYC rearrangement) </plain></SENT>
<SENT sid="3" pm="."><plain>The immunophenotype of the <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells in the 2 groups was similar </plain></SENT>
<SENT sid="4" pm="."><plain>Although children with MYC+ and MYC- <z:hpo ids='HP_0002664'>neoplasms</z:hpo> were treated with chemotherapy regimens appropriate for Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, adults with MYC- <z:hpo ids='HP_0002665'>lymphomas</z:hpo> received less aggressive therapy usually given for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Survival analysis showed that adults in the MYC- group had an inferior outcome compared with adults with MYC+ disease </plain></SENT>
<SENT sid="6" pm="."><plain>Provisional identification of MYC- <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with typical Burkitt morphologic features as an entity separate from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> will facilitate further studies and possible categorization as a separate entity </plain></SENT>
</text></document>